C. Terragna; M. Renzulli; D. Remondini; E. Tagliafico; E. Roncaglia; P. Tosi; E. Zamagni; P. Tacchetti; G. Perrone; M. Ceccolini; G. Martinelli; M. Baccarani; M. Cavo, Gene expression profiling (gep) of myeloma (MM) cells to predict attainment near complete response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed MM, in: , «BLOOD», 2007, 108(atti di: 48th American Society for Hematology Annual Meeting, Orlando, Florida, December 9-12, 2006) [Abstract]
Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA., Neuropathy in multiple myeloma treated with thalidomide: a prospective study., «NEUROLOGY», 2007, 69, pp. 573 - 581 [Scientific article]
Terragna, Carolina; Renzulli, Matteo; Remondini, Daniel; Tagliafico, E.; Roncaglia, E.; Tosi, Patrizia; Zamagni, Elena; Tacchetti, Paola; Perrone, Giulia; Ceccolini, Michela; Brioli, A. m.; Martinelli, Giovanni; Baccarani, Michele; Cavo, Michele, Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep), in: Haematologica, Vienna, Austria, 2007, 92(s2), pp. 92 - 92 (atti di: 12th Congress of the European Hematology Association, Vienna, Austria, June 7-10, 2007) [Abstract]
Terragna C.; Renzulli M.; Remondini D.; Tagliafico E.; Roncaglia E.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Ceccolini M.; Brioli AM.; Martinelli G.; Baccarani M.; Cavo M., Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep), in: , «HAEMATOLOGICA», 2007, 92(s2)(atti di: 12th Congress of the European Hematology Association, Vienna, Austria, June 7-10, 2007) [Abstract]
Zamagni E.; Valdrè L.; Palareti G.; Cavo M., Prevention of VTE in multiple myeloma patients., «THROMBOSIS RESEARCH», 2007, 120 suppl 2, pp. S133 - S136 [Scientific article]
Cavo M; Tosi P; Zamagni E; Cellini C; Tacchetti P; Patriarca F; Di Raimondo F; Volpe E; Ronconi S; Cangini D; Narni F; Carubelli A; Masini L; Catalano L; Fiacchini M; de Vivo A; Gozzetti A; Lazzaro A; Tura S; Baccarani M., Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study., «JOURNAL OF CLINICAL ONCOLOGY», 2007, 25, pp. 2434 - 2441 [Scientific article]
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S., 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma., «WORLD JOURNAL OF SURGICAL ONCOLOGY», 2007, 5, pp. 68 - 68 [Scientific article]
C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Montini; M. Cavo; S. Fanti., Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma, in: , «THE JOURNAL OF NUCLEAR MEDICINE», 2006, 47S, pp. 478p - 478p (atti di: SNM annual meeting,, 3-7 June,, San Diego, USA.) [Abstract]
Tosi P; Zamagni E; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Baccarani M; Cavo M., Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation., «ANNALS OF HEMATOLOGY», 2006, 85(8), pp. 549 - 551 [Scientific article]
Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M., First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2006, 76, pp. 399 - 404 [Scientific article]
Palumbo A; Bringhen S; Caravita T; Merla E; Capparella V; Callea V; Cangialosi C; Grasso M; Rossini F; Galli M; Catalano L; Zamagni E; Petrucci MT; De Stefano V; Ceccarelli M; Ambrosini MT; Avonto I; Falco P; Ciccone G; Liberati AM; Musto P; Boccadoro M; Italian Multiple Myeloma Network; GIMEMA., Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial., «THE LANCET», 2006, 367(9513), pp. 825 - 831 [Scientific article]
Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M., Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone., «BLOOD», 2006, 108, pp. 3951 - 3952 [Scientific article]
Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L., Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission., «JOURNAL OF CLINICAL ONCOLOGY», 2006, 24, pp. e4 - e5 [Scientific article]
Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Cavo M.; Fanti S., Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2006, 33(5), pp. 525 - 531 [Scientific article]
C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato; G. Montini; S. Fanti., Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions, in: , «THE JOURNAL OF NUCLEAR MEDICINE», 2006, 47S, pp. 52p - 52p (atti di: SNM annual meeting, 3-7 June, San Diego, USA) [Abstract]
